首页> 外文期刊>Glia >Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: Dual roles of mitogen-activated protein kinase signaling pathways
【24h】

Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: Dual roles of mitogen-activated protein kinase signaling pathways

机译:凝血酶激活的小胶质细胞促成大鼠中脑培养物中多巴胺能神经元的死亡:促分裂原激活的蛋白激酶信号通路的双重作用

获取原文
获取原文并翻译 | 示例
       

摘要

This study evaluated the role of thrombin-activated microglia in the neurodegeneration of mesencephalic cultures. Immunocytochemical and biochemical evidence indicated that in co-cultures consisting of rat cortical microglia and mesencephalic neurons, thrombin led to nonselective loss of mesencephalic neurons. Accompanying neurodegeneration, microglial activation was obvious, evidenced by expression of tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-1 beta, inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) and by increasing production of TNF-alpha and nitric oxide (NO). In mesencephalic neurons treated with conditioned media (CM) taken from thrombin-activated microglia, the number of dopaminergic neurons was significantly attenuated. The neurotoxicity of the CM was diminished when it was derived from microglia co-treated with thrombin and either an extracellular signal-regulated kinase 1/2 (ERK1/2) pathway inhibitor (PD98059) or a p38-mitogen-activated protein kinase (p38-MAPK) inhibitor (SB203580). Moreover, jun N-terminal kinase (JNK) and p38-MAPK were activated in mesencephalic neurons treated with CM of thrombin-activated microglia. Inhibition of JNK and p38-MAPK rescued the dopaminergic neurons. Collectively, these results indicate that thrombin-activated microglia induce neurodegeneration in cultured mesencephalic neurons and that the MAPKs actively participate in both microglial activation and neurodegeneration. The present data carefully suggest that microglial activation triggered by thrombin may be involved in the neuropathological processes of doparninergic neuronal cell death that occur in Parkinson's disease. (c) 2005 Wiley-Liss, Inc.
机译:这项研究评估了凝血酶激活的小胶质细胞在中脑培养物神经变性中的作用。免疫细胞化学和生物化学证据表明,在由大鼠皮层小胶质细胞和中脑神经元组成的共培养物中,凝血酶导致中脑神经元的非选择性损失。伴随神经退行性变,小胶质细胞活化很明显,表现为肿瘤坏死因子(TNF)-α,白介素(IL)-6,IL-1β,诱导型一氧化氮合酶(iNOS)和环氧合酶2(COX-2)的表达并增加TNF-α和一氧化氮(NO)的产量。在取自凝血酶激活的小胶质细胞的条件培养基(CM)处理的中脑神经元中,多巴胺能神经元的数量明显减少。当CM源自与凝血酶和细胞外信号调节激酶1/2(ERK1 / 2)途径抑制剂(PD98059)或p38促分裂原激活蛋白激酶(p38)共同治疗的小胶质细胞时,其神经毒性降低。 -MAPK)抑制剂(SB203580)。此外,在凝血酶激活的小胶质细胞的CM处理后的中脑神经元中,jun N末端激酶(JNK)和p38-MAPK被激活。抑制JNK和p38-MAPK可拯救多巴胺能神经元。总体而言,这些结果表明,凝血酶激活的小胶质细胞在培养的中脑神经元中诱导神经变性,并且MAPKs积极参与小胶质细胞的激活和神经变性。本数据仔细地表明,由凝血酶触发的小胶质细胞活化可能与帕金森氏病中发生的多巴能神经元细胞死亡的神经病理过程有关。 (c)2005 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号